Leitao Xu

Title: Leitao Xu: Innovator in Vaccine Development

Introduction

Leitao Xu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in vaccine development. His work focuses on enhancing immunogenicity and the effectiveness of vaccines.

Latest Patents

Leitao Xu holds a patent for a recombinant varicella-zoster virus (VZV) vaccine. This innovative vaccine includes a fusion protein formed by an amino acid sequence of an extracellular domain of a recombinant glycoprotein gE of a live attenuated VZV strain (OKA strain) gene and an Fc fragment of human immunoglobulin. The patent outlines the preparation and use of the fusion protein, a corresponding recombinant gene, and a eukaryotic expression vector. The fusion protein demonstrates prominent immunogenicity and can induce high-level expression of neutralizing antibodies in serum.

Career Highlights

Leitao Xu is associated with Beijing Luzhu Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in vaccine innovation.

Collaborations

Leitao Xu collaborates with notable colleagues, including Jian Kong and Pei Hong Jiang. Their combined expertise contributes to the success of their projects and the advancement of vaccine technology.

Conclusion

Leitao Xu's contributions to vaccine development, particularly through his patented recombinant varicella-zoster virus vaccine, highlight his role as an innovator in biotechnology. His work continues to impact the field positively.